We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$20.5M
AUM Growth
-$13.3M
Cap. Flow
-$13.8M
Cap. Flow %
-67.25%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$22M

Sector Composition

Rank Sector Weight
1 Financials 59.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CME icon
1
CME Group
CME
$92.2B
$12.2M 59.41%
102,553
– –
ASHR icon
2
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.35B
$8.32M 40.59%
+331,200
New +$8.24M
IBB icon
3
iShares Biotechnology ETF
IBB
$9.31B
– –
-249,000
Closed -$22M

Similar funds

GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Brevan Howard Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Brevan Howard Capital Management held 3 positions worth $20.5M, down 39% from $33.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Brevan Howard Capital Management withdrew a net $13.8M in Q1 2017, closing 1 position. Its most notable exit was iShares Biotechnology ETF, an estimated $22M position sold in full.

By sector, the portfolio is most concentrated in Financials at 59% of assets, up from 35% a quarter earlier.

  • Brevan Howard Capital Management fully exited iShares Biotechnology ETF in Q1 2017, selling an estimated $22M.
  • Brevan Howard Capital Management's ten largest holdings make up 100% of its $20.5M portfolio in Q1 2017.
  • Brevan Howard Capital Management opened 1 new position and closed 1 in Q1 2017.
  • Brevan Howard Capital Management's portfolio value fell 39% quarter-over-quarter to $20.5M.

Based on Brevan Howard Capital Management's 13F filing for Q1 2017, filed 15 May 2017.